

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | desmosome organization (GO:0002934) | 5.46539760 |
| 2 | GDP-mannose metabolic process (GO:0019673) | 4.86976504 |
| 3 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 4.24796538 |
| 4 | folic acid metabolic process (GO:0046655) | 4.24042801 |
| 5 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.15905663 |
| 6 | glycine metabolic process (GO:0006544) | 4.08084393 |
| 7 | actin filament depolymerization (GO:0030042) | 3.96233187 |
| 8 | nucleobase biosynthetic process (GO:0046112) | 3.95487382 |
| 9 | purine nucleobase biosynthetic process (GO:0009113) | 3.93782914 |
| 10 | sulfur amino acid catabolic process (GO:0000098) | 3.62345298 |
| 11 | serine family amino acid biosynthetic process (GO:0009070) | 3.61827525 |
| 12 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.58866451 |
| 13 | activation of Rac GTPase activity (GO:0032863) | 3.58687335 |
| 14 | formation of translation preinitiation complex (GO:0001731) | 3.57851856 |
| 15 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.54858407 |
| 16 | L-phenylalanine metabolic process (GO:0006558) | 3.54858407 |
| 17 | serine family amino acid catabolic process (GO:0009071) | 3.49746676 |
| 18 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.47258591 |
| 19 | proline biosynthetic process (GO:0006561) | 3.44812167 |
| 20 | hemidesmosome assembly (GO:0031581) | 3.44651175 |
| 21 | tolerance induction (GO:0002507) | 3.44292892 |
| 22 | serine family amino acid metabolic process (GO:0009069) | 3.41426702 |
| 23 | cysteine metabolic process (GO:0006534) | 3.41129724 |
| 24 | protein carboxylation (GO:0018214) | 3.41047218 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.41047218 |
| 26 | proteasome assembly (GO:0043248) | 3.33818297 |
| 27 | positive regulation of pseudopodium assembly (GO:0031274) | 3.33339097 |
| 28 | regulation of cholesterol metabolic process (GO:0090181) | 3.33044812 |
| 29 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.32899418 |
| 30 | apoptotic process involved in morphogenesis (GO:0060561) | 3.30166325 |
| 31 | interferon-gamma secretion (GO:0072643) | 3.27899556 |
| 32 | DNA deamination (GO:0045006) | 3.26784920 |
| 33 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.25771097 |
| 34 | L-phenylalanine catabolic process (GO:0006559) | 3.25771097 |
| 35 | regulation of water loss via skin (GO:0033561) | 3.25195865 |
| 36 | epithelial cell-cell adhesion (GO:0090136) | 3.21171336 |
| 37 | protein retention in ER lumen (GO:0006621) | 3.17491836 |
| 38 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.16678061 |
| 39 | cell-cell junction maintenance (GO:0045217) | 3.13452709 |
| 40 | multicellular organismal water homeostasis (GO:0050891) | 3.12779809 |
| 41 | glutathione biosynthetic process (GO:0006750) | 3.12756627 |
| 42 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.10034802 |
| 43 | nitrogen cycle metabolic process (GO:0071941) | 3.08338325 |
| 44 | glyoxylate metabolic process (GO:0046487) | 3.06636164 |
| 45 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 3.06427888 |
| 46 | mannose metabolic process (GO:0006013) | 3.05954105 |
| 47 | proline metabolic process (GO:0006560) | 3.05585895 |
| 48 | intestinal epithelial cell development (GO:0060576) | 3.02202241 |
| 49 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 3.02049069 |
| 50 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.00016660 |
| 51 | ribosome assembly (GO:0042255) | 2.99760692 |
| 52 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.97760852 |
| 53 | aromatic amino acid family catabolic process (GO:0009074) | 2.97752760 |
| 54 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.95775229 |
| 55 | cellular response to virus (GO:0098586) | 2.94871403 |
| 56 | glucose catabolic process (GO:0006007) | 2.94577509 |
| 57 | amyloid precursor protein metabolic process (GO:0042982) | 2.94163264 |
| 58 | establishment of skin barrier (GO:0061436) | 2.93685185 |
| 59 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.93565985 |
| 60 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.93167508 |
| 61 | maturation of SSU-rRNA (GO:0030490) | 2.93010753 |
| 62 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.91982437 |
| 63 | glucose 6-phosphate metabolic process (GO:0051156) | 2.91944578 |
| 64 | homocysteine metabolic process (GO:0050667) | 2.91676241 |
| 65 | folic acid-containing compound metabolic process (GO:0006760) | 2.90380897 |
| 66 | L-serine metabolic process (GO:0006563) | 2.90200582 |
| 67 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.88802779 |
| 68 | regulation of defense response to virus by virus (GO:0050690) | 2.87640743 |
| 69 | tetrahydrofolate metabolic process (GO:0046653) | 2.84699053 |
| 70 | kynurenine metabolic process (GO:0070189) | 2.84178947 |
| 71 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.83837939 |
| 72 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.82521493 |
| 73 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.82329256 |
| 74 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.81502675 |
| 75 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.80615955 |
| 76 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.80013660 |
| 77 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.79922641 |
| 78 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.79444836 |
| 79 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.79193181 |
| 80 | amyloid precursor protein catabolic process (GO:0042987) | 2.79111134 |
| 81 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.78834463 |
| 82 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.78626908 |
| 83 | regulation of pseudopodium assembly (GO:0031272) | 2.78613504 |
| 84 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.78107545 |
| 85 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.77647047 |
| 86 | tryptophan catabolic process (GO:0006569) | 2.77310619 |
| 87 | indole-containing compound catabolic process (GO:0042436) | 2.77310619 |
| 88 | indolalkylamine catabolic process (GO:0046218) | 2.77310619 |
| 89 | ribosomal large subunit biogenesis (GO:0042273) | 2.76829128 |
| 90 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.75539258 |
| 91 | intestinal cholesterol absorption (GO:0030299) | 2.75188190 |
| 92 | DNA replication initiation (GO:0006270) | 2.74878426 |
| 93 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.73807799 |
| 94 | ribosome biogenesis (GO:0042254) | 2.72869533 |
| 95 | atrioventricular valve morphogenesis (GO:0003181) | 2.71808878 |
| 96 | DNA strand elongation (GO:0022616) | 2.71685378 |
| 97 | NIK/NF-kappaB signaling (GO:0038061) | 2.71438921 |
| 98 | semaphorin-plexin signaling pathway (GO:0071526) | 2.71334484 |
| 99 | regulation of viral release from host cell (GO:1902186) | 2.71303236 |
| 100 | regulation of extracellular matrix disassembly (GO:0010715) | 2.70897604 |
| 101 | lysine metabolic process (GO:0006553) | 2.70746152 |
| 102 | lysine catabolic process (GO:0006554) | 2.70746152 |
| 103 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.70227583 |
| 104 | phospholipid efflux (GO:0033700) | 2.70089485 |
| 105 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.70055873 |
| 106 | cellular zinc ion homeostasis (GO:0006882) | 2.69780162 |
| 107 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.69292933 |
| 108 | regulation of respiratory burst (GO:0060263) | 2.68166413 |
| 109 | nucleoside salvage (GO:0043174) | 2.67730213 |
| 110 | basement membrane organization (GO:0071711) | 2.67059276 |
| 111 | regulation of gene silencing by miRNA (GO:0060964) | 2.66734964 |
| 112 | regulation of gene silencing by RNA (GO:0060966) | 2.66734964 |
| 113 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.66734964 |
| 114 | sulfur amino acid biosynthetic process (GO:0000097) | 2.66697126 |
| 115 | regulation of ruffle assembly (GO:1900027) | 2.66374376 |
| 116 | folic acid transport (GO:0015884) | 2.66362618 |
| 117 | tryptophan metabolic process (GO:0006568) | 2.66069031 |
| 118 | amino-acid betaine metabolic process (GO:0006577) | 2.64569437 |
| 119 | NADH metabolic process (GO:0006734) | 2.63696241 |
| 120 | positive regulation of histone deacetylation (GO:0031065) | 2.62286447 |
| 121 | DNA replication checkpoint (GO:0000076) | 2.61732945 |
| 122 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.61447824 |
| 123 | pteridine-containing compound metabolic process (GO:0042558) | 2.61204124 |
| 124 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.60645598 |
| 125 | negative regulation of ligase activity (GO:0051352) | 2.60645598 |
| 126 | viral transcription (GO:0019083) | 2.60525309 |
| 127 | negative regulation of viral release from host cell (GO:1902187) | 2.60202355 |
| 128 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.59760746 |
| 129 | pentose-phosphate shunt (GO:0006098) | 2.59356388 |
| 130 | urea metabolic process (GO:0019627) | 2.59311353 |
| 131 | urea cycle (GO:0000050) | 2.59311353 |
| 132 | ribosomal small subunit assembly (GO:0000028) | 2.59254239 |
| 133 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.58572703 |
| 134 | protein insertion into membrane (GO:0051205) | 2.58341824 |
| 135 | aromatic amino acid family metabolic process (GO:0009072) | 2.58210792 |
| 136 | mitotic metaphase plate congression (GO:0007080) | 2.57916543 |
| 137 | cell junction maintenance (GO:0034331) | 2.57506404 |
| 138 | translational initiation (GO:0006413) | 2.56542445 |
| 139 | regulation of cholesterol homeostasis (GO:2000188) | 2.55979283 |
| 140 | negative regulation of sterol transport (GO:0032372) | 2.55142539 |
| 141 | negative regulation of cholesterol transport (GO:0032375) | 2.55142539 |
| 142 | translational elongation (GO:0006414) | 2.54760999 |
| 143 | negative regulation of fibrinolysis (GO:0051918) | 2.54702861 |
| 144 | high-density lipoprotein particle remodeling (GO:0034375) | 2.54178393 |
| 145 | translational termination (GO:0006415) | 2.53649247 |
| 146 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.53179135 |
| 147 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.53179135 |
| 148 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.52158160 |
| 149 | primary alcohol catabolic process (GO:0034310) | 2.51023964 |
| 150 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.50906835 |
| 151 | lung epithelium development (GO:0060428) | 2.50858028 |
| 152 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.50681284 |
| 153 | IMP biosynthetic process (GO:0006188) | 2.49637862 |
| 154 | COPI coating of Golgi vesicle (GO:0048205) | 2.49272990 |
| 155 | Golgi transport vesicle coating (GO:0048200) | 2.49272990 |
| 156 | water homeostasis (GO:0030104) | 2.49145276 |
| 157 | intestinal absorption (GO:0050892) | 2.48906319 |
| 158 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.48730049 |
| 159 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.47844376 |
| 160 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.47844376 |
| 161 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.47844376 |
| 162 | L-methionine salvage (GO:0071267) | 2.47770847 |
| 163 | L-methionine biosynthetic process (GO:0071265) | 2.47770847 |
| 164 | amino acid salvage (GO:0043102) | 2.47770847 |
| 165 | heme transport (GO:0015886) | 2.47311633 |
| 166 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.47279076 |
| 167 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.47279076 |
| 168 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.46385183 |
| 169 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.46385183 |
| 170 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.46290596 |
| 171 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.46032333 |
| 172 | flavonoid metabolic process (GO:0009812) | 2.43827028 |
| 173 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.43817625 |
| 174 | regulation of extracellular matrix organization (GO:1903053) | 2.43006892 |
| 175 | ethanol metabolic process (GO:0006067) | 2.41566515 |
| 176 | negative regulation of cell size (GO:0045792) | 2.40925671 |
| 177 | epoxygenase P450 pathway (GO:0019373) | 2.40505888 |
| 178 | viral protein processing (GO:0019082) | 2.39520159 |
| 179 | regulation of actin nucleation (GO:0051125) | 2.38984626 |
| 180 | virion assembly (GO:0019068) | 2.37435736 |
| 181 | regulation of Cdc42 GTPase activity (GO:0043088) | 2.36588266 |
| 182 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.34982521 |
| 183 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.34624026 |
| 184 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.33790073 |
| 185 | regulation of cellular extravasation (GO:0002691) | 2.33493658 |
| 186 | maternal placenta development (GO:0001893) | 2.33375197 |
| 187 | nuclear envelope reassembly (GO:0031468) | 2.33327902 |
| 188 | mitotic nuclear envelope reassembly (GO:0007084) | 2.33327902 |
| 189 | regulation of triglyceride catabolic process (GO:0010896) | 2.31228155 |
| 190 | citrulline biosynthetic process (GO:0019240) | 2.30158664 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.28923178 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.44716348 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.42349371 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.36984146 |
| 5 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.86349630 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.75909230 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.61082968 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.53885608 |
| 9 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 2.53397157 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.50360487 |
| 11 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.48109083 |
| 12 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.46786094 |
| 13 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.41831894 |
| 14 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.39604141 |
| 15 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.35235691 |
| 16 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.34263359 |
| 17 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.31980990 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.31767117 |
| 19 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.30510612 |
| 20 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.25116759 |
| 21 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.24241839 |
| 22 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.22861519 |
| 23 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.22387898 |
| 24 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.21405889 |
| 25 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.10193922 |
| 26 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.04925399 |
| 27 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.95376600 |
| 28 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.93919540 |
| 29 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.92450603 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.90380644 |
| 31 | P68_20966046_ChIP-Seq_HELA_Human | 1.88345174 |
| 32 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.87457542 |
| 33 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.84886554 |
| 34 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.83535916 |
| 35 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.83297060 |
| 36 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.81522698 |
| 37 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.80499532 |
| 38 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.80308997 |
| 39 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.78720372 |
| 40 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.75761286 |
| 41 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.74476628 |
| 42 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.69743529 |
| 43 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.69228744 |
| 44 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.68518601 |
| 45 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.67963377 |
| 46 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.67731107 |
| 47 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.67633751 |
| 48 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.66002877 |
| 49 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.65830627 |
| 50 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.65394195 |
| 51 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.65334682 |
| 52 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.63816286 |
| 53 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.61606996 |
| 54 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.61250075 |
| 55 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.60784893 |
| 56 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.58790682 |
| 57 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.56521465 |
| 58 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.55489629 |
| 59 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.54151859 |
| 60 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.52529556 |
| 61 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.52454669 |
| 62 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.52397382 |
| 63 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.51490730 |
| 64 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.50712485 |
| 65 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.48363108 |
| 66 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.46651209 |
| 67 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.45388649 |
| 68 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.45068406 |
| 69 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.44627307 |
| 70 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.42588719 |
| 71 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.41615928 |
| 72 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.41325049 |
| 73 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.40717773 |
| 74 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.39470823 |
| 75 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.39279852 |
| 76 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.38766648 |
| 77 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.38127053 |
| 78 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.37690035 |
| 79 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.37319390 |
| 80 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36879678 |
| 81 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.36599534 |
| 82 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.34722944 |
| 83 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.34425801 |
| 84 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.34021840 |
| 85 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.33834606 |
| 86 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.32925785 |
| 87 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.31304754 |
| 88 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.31108589 |
| 89 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.31043358 |
| 90 | SA1_27219007_Chip-Seq_Bcells_Human | 1.30858975 |
| 91 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.30188504 |
| 92 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.30146163 |
| 93 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.29636443 |
| 94 | MAF_26560356_Chip-Seq_TH2_Human | 1.29169494 |
| 95 | * MAF_26560356_Chip-Seq_TH1_Human | 1.28693092 |
| 96 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.28515692 |
| 97 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.28087750 |
| 98 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.27018154 |
| 99 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.26833690 |
| 100 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.26645026 |
| 101 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.26251518 |
| 102 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25566543 |
| 103 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.25273697 |
| 104 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.24785862 |
| 105 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.24297877 |
| 106 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.23933786 |
| 107 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.23112269 |
| 108 | UTX_26944678_Chip-Seq_JUKART_Human | 1.22404289 |
| 109 | KDM2B_26808549_Chip-Seq_K562_Human | 1.21900948 |
| 110 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.21428700 |
| 111 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.20113377 |
| 112 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.19853403 |
| 113 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.18885950 |
| 114 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.18756684 |
| 115 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.18060481 |
| 116 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.18046086 |
| 117 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.17992683 |
| 118 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.17772599 |
| 119 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.17134097 |
| 120 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.16999405 |
| 121 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.16769222 |
| 122 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.16247719 |
| 123 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.16133872 |
| 124 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.16114780 |
| 125 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.15475104 |
| 126 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.13051945 |
| 127 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.11967261 |
| 128 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.11915203 |
| 129 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.10996500 |
| 130 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.10106485 |
| 131 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10068755 |
| 132 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.09680390 |
| 133 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.09150544 |
| 134 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.09064987 |
| 135 | ATF3_27146783_Chip-Seq_COLON_Human | 1.08747277 |
| 136 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08542670 |
| 137 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.07886699 |
| 138 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.06483446 |
| 139 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.06164296 |
| 140 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.05685155 |
| 141 | MYC_22102868_ChIP-Seq_BL_Human | 1.04181748 |
| 142 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.03382165 |
| 143 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.03220363 |
| 144 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02521566 |
| 145 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02287980 |
| 146 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02278538 |
| 147 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.01922712 |
| 148 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01803801 |
| 149 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.01597932 |
| 150 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.01312472 |
| 151 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01211332 |
| 152 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.00799140 |
| 153 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00662395 |
| 154 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.99756313 |
| 155 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.98229682 |
| 156 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.98134678 |
| 157 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.98049219 |
| 158 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98038747 |
| 159 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.97520898 |
| 160 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.95150258 |
| 161 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.94743136 |
| 162 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.94325098 |
| 163 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.93791109 |
| 164 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.92903047 |
| 165 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.92479934 |
| 166 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.92433976 |
| 167 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.89876867 |
| 168 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.89781340 |
| 169 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.89617501 |
| 170 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89282480 |
| 171 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.87004933 |
| 172 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.86539519 |
| 173 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.85983447 |
| 174 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.85924185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.64462806 |
| 2 | MP0005360_urolithiasis | 4.26024238 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 3.89522595 |
| 4 | MP0003693_abnormal_embryo_hatching | 3.79003794 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.42427477 |
| 6 | MP0005365_abnormal_bile_salt | 3.25899657 |
| 7 | MP0009840_abnormal_foam_cell | 3.02922344 |
| 8 | MP0004957_abnormal_blastocyst_morpholog | 2.70906345 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.66196270 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.60634109 |
| 11 | MP0010234_abnormal_vibrissa_follicle | 2.55985215 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.33141778 |
| 13 | MP0010352_gastrointestinal_tract_polyps | 2.16372583 |
| 14 | MP0003111_abnormal_nucleus_morphology | 2.12594298 |
| 15 | MP0004264_abnormal_extraembryonic_tissu | 2.04970542 |
| 16 | MP0001873_stomach_inflammation | 2.02495333 |
| 17 | MP0002796_impaired_skin_barrier | 1.99624141 |
| 18 | MP0005083_abnormal_biliary_tract | 1.92856716 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 1.91015354 |
| 20 | MP0003252_abnormal_bile_duct | 1.87452839 |
| 21 | MP0008260_abnormal_autophagy | 1.83978177 |
| 22 | MP0003705_abnormal_hypodermis_morpholog | 1.83280226 |
| 23 | MP0005332_abnormal_amino_acid | 1.83244290 |
| 24 | MP0000678_abnormal_parathyroid_gland | 1.82586958 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 1.82362158 |
| 26 | MP0010329_abnormal_lipoprotein_level | 1.78566416 |
| 27 | MP0003172_abnormal_lysosome_physiology | 1.75184612 |
| 28 | MP0003077_abnormal_cell_cycle | 1.74851020 |
| 29 | MP0003866_abnormal_defecation | 1.74845022 |
| 30 | MP0010155_abnormal_intestine_physiology | 1.74048700 |
| 31 | MP0010030_abnormal_orbit_morphology | 1.67860582 |
| 32 | MP0010094_abnormal_chromosome_stability | 1.65980047 |
| 33 | MP0000537_abnormal_urethra_morphology | 1.64493619 |
| 34 | MP0002138_abnormal_hepatobiliary_system | 1.63993321 |
| 35 | MP0003941_abnormal_skin_development | 1.63410942 |
| 36 | MP0004947_skin_inflammation | 1.60012440 |
| 37 | MP0003436_decreased_susceptibility_to | 1.59891836 |
| 38 | MP0003718_maternal_effect | 1.59597960 |
| 39 | MP0005501_abnormal_skin_physiology | 1.51134326 |
| 40 | MP0003191_abnormal_cellular_cholesterol | 1.50472793 |
| 41 | MP0004858_abnormal_nervous_system | 1.48192318 |
| 42 | MP0003186_abnormal_redox_activity | 1.47606849 |
| 43 | MP0009643_abnormal_urine_homeostasis | 1.44116510 |
| 44 | MP0001730_embryonic_growth_arrest | 1.43803287 |
| 45 | MP0000858_altered_metastatic_potential | 1.41448834 |
| 46 | MP0003763_abnormal_thymus_physiology | 1.39571474 |
| 47 | MP0003195_calcinosis | 1.35928655 |
| 48 | MP0008932_abnormal_embryonic_tissue | 1.32814025 |
| 49 | MP0003315_abnormal_perineum_morphology | 1.30736387 |
| 50 | MP0000609_abnormal_liver_physiology | 1.30498213 |
| 51 | MP0001764_abnormal_homeostasis | 1.27626836 |
| 52 | MP0005319_abnormal_enzyme/_coenzyme | 1.27160558 |
| 53 | MP0004782_abnormal_surfactant_physiolog | 1.25460896 |
| 54 | MP0008058_abnormal_DNA_repair | 1.25412074 |
| 55 | MP0009053_abnormal_anal_canal | 1.23182806 |
| 56 | MP0001664_abnormal_digestion | 1.22809574 |
| 57 | MP0001765_abnormal_ion_homeostasis | 1.21459444 |
| 58 | MP0000467_abnormal_esophagus_morphology | 1.20592184 |
| 59 | MP0010678_abnormal_skin_adnexa | 1.17326354 |
| 60 | MP0008007_abnormal_cellular_replicative | 1.15062207 |
| 61 | MP0002098_abnormal_vibrissa_morphology | 1.14629852 |
| 62 | MP0003890_abnormal_embryonic-extraembry | 1.14446861 |
| 63 | MP0005025_abnormal_response_to | 1.13936829 |
| 64 | MP0003786_premature_aging | 1.13014261 |
| 65 | MP0005409_darkened_coat_color | 1.09891734 |
| 66 | MP0002249_abnormal_larynx_morphology | 1.09634460 |
| 67 | MP0001756_abnormal_urination | 1.09568924 |
| 68 | MP0003119_abnormal_digestive_system | 1.09493183 |
| 69 | MP0005075_abnormal_melanosome_morpholog | 1.08409045 |
| 70 | MP0005220_abnormal_exocrine_pancreas | 1.08180799 |
| 71 | MP0003878_abnormal_ear_physiology | 1.06167626 |
| 72 | MP0005377_hearing/vestibular/ear_phenot | 1.06167626 |
| 73 | MP0000350_abnormal_cell_proliferation | 1.05868618 |
| 74 | MP0000490_abnormal_crypts_of | 1.05166551 |
| 75 | MP0004381_abnormal_hair_follicle | 1.02448660 |
| 76 | MP0005464_abnormal_platelet_physiology | 1.02385247 |
| 77 | MP0002089_abnormal_postnatal_growth/wei | 1.01799319 |
| 78 | MP0001672_abnormal_embryogenesis/_devel | 1.00641686 |
| 79 | MP0005380_embryogenesis_phenotype | 1.00641686 |
| 80 | MP0005451_abnormal_body_composition | 0.99609857 |
| 81 | MP0009931_abnormal_skin_appearance | 0.99135190 |
| 82 | MP0003183_abnormal_peptide_metabolism | 0.98894809 |
| 83 | MP0001697_abnormal_embryo_size | 0.96710862 |
| 84 | MP0006035_abnormal_mitochondrial_morpho | 0.96210263 |
| 85 | MP0000598_abnormal_liver_morphology | 0.96190201 |
| 86 | MP0006036_abnormal_mitochondrial_physio | 0.95612228 |
| 87 | MP0000579_abnormal_nail_morphology | 0.94392416 |
| 88 | MP0002080_prenatal_lethality | 0.94136304 |
| 89 | MP0001216_abnormal_epidermal_layer | 0.93013769 |
| 90 | MP0005084_abnormal_gallbladder_morpholo | 0.92933975 |
| 91 | MP0005076_abnormal_cell_differentiation | 0.92631828 |
| 92 | MP0000462_abnormal_digestive_system | 0.91651400 |
| 93 | MP0002060_abnormal_skin_morphology | 0.90949287 |
| 94 | MP0000685_abnormal_immune_system | 0.90453243 |
| 95 | MP0010771_integument_phenotype | 0.90271935 |
| 96 | MP0002088_abnormal_embryonic_growth/wei | 0.89558537 |
| 97 | MP0003984_embryonic_growth_retardation | 0.89276488 |
| 98 | MP0000003_abnormal_adipose_tissue | 0.88919910 |
| 99 | MP0000477_abnormal_intestine_morphology | 0.88239514 |
| 100 | MP0005023_abnormal_wound_healing | 0.87365008 |
| 101 | MP0002118_abnormal_lipid_homeostasis | 0.86009958 |
| 102 | MP0002086_abnormal_extraembryonic_tissu | 0.85441384 |
| 103 | MP0001663_abnormal_digestive_system | 0.85365591 |
| 104 | MP0005166_decreased_susceptibility_to | 0.84259456 |
| 105 | MP0004197_abnormal_fetal_growth/weight/ | 0.82394929 |
| 106 | MP0001845_abnormal_inflammatory_respons | 0.82021627 |
| 107 | MP0005381_digestive/alimentary_phenotyp | 0.81702391 |
| 108 | MP0002085_abnormal_embryonic_tissue | 0.81048335 |
| 109 | MP0008469_abnormal_protein_level | 0.80834154 |
| 110 | MP0002166_altered_tumor_susceptibility | 0.80658080 |
| 111 | MP0009379_abnormal_foot_pigmentation | 0.80300332 |
| 112 | MP0005636_abnormal_mineral_homeostasis | 0.79916992 |
| 113 | MP0001348_abnormal_lacrimal_gland | 0.78932468 |
| 114 | MP0001819_abnormal_immune_cell | 0.78787800 |
| 115 | MP0003453_abnormal_keratinocyte_physiol | 0.78787103 |
| 116 | MP0002452_abnormal_antigen_presenting | 0.78358681 |
| 117 | MP0000358_abnormal_cell_content/ | 0.77747121 |
| 118 | MP0009278_abnormal_bone_marrow | 0.77729857 |
| 119 | MP0001293_anophthalmia | 0.77066559 |
| 120 | MP0009672_abnormal_birth_weight | 0.76729528 |
| 121 | MP0000470_abnormal_stomach_morphology | 0.76722213 |
| 122 | MP0005408_hypopigmentation | 0.75895622 |
| 123 | MP0002084_abnormal_developmental_patter | 0.75198720 |
| 124 | MP0001849_ear_inflammation | 0.74994763 |
| 125 | MP0002132_abnormal_respiratory_system | 0.74612053 |
| 126 | MP0003879_abnormal_hair_cell | 0.74507157 |
| 127 | MP0003567_abnormal_fetal_cardiomyocyte | 0.73986084 |
| 128 | MP0004133_heterotaxia | 0.73951509 |
| 129 | MP0002420_abnormal_adaptive_immunity | 0.73935220 |
| 130 | MP0002419_abnormal_innate_immunity | 0.73137483 |
| 131 | MP0000367_abnormal_coat/_hair | 0.72365788 |
| 132 | MP0005387_immune_system_phenotype | 0.72342596 |
| 133 | MP0001790_abnormal_immune_system | 0.72342596 |
| 134 | MP0000377_abnormal_hair_follicle | 0.71805193 |
| 135 | MP0003123_paternal_imprinting | 0.71796580 |
| 136 | MP0000516_abnormal_urinary_system | 0.71709980 |
| 137 | MP0005367_renal/urinary_system_phenotyp | 0.71709980 |
| 138 | MP0002254_reproductive_system_inflammat | 0.71442332 |
| 139 | MP0002019_abnormal_tumor_incidence | 0.71420563 |
| 140 | MP0004185_abnormal_adipocyte_glucose | 0.71397037 |
| 141 | MP0003300_gastrointestinal_ulcer | 0.71294503 |
| 142 | MP0002136_abnormal_kidney_physiology | 0.70288350 |
| 143 | MP0005395_other_phenotype | 0.68718423 |
| 144 | MP0005266_abnormal_metabolism | 0.68070007 |
| 145 | MP0003566_abnormal_cell_adhesion | 0.66293736 |
| 146 | MP0000313_abnormal_cell_death | 0.66083058 |
| 147 | MP0002160_abnormal_reproductive_system | 0.64157107 |
| 148 | MP0000566_synostosis | 0.63897881 |
| 149 | MP0008057_abnormal_DNA_replication | 0.62613339 |
| 150 | MP0005389_reproductive_system_phenotype | 0.62078298 |
| 151 | MP0002111_abnormal_tail_morphology | 0.61688634 |
| 152 | MP0002653_abnormal_ependyma_morphology | 0.61417008 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.70208613 |
| 2 | Hypobetalipoproteinemia (HP:0003563) | 4.34729934 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.23448841 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 4.04584082 |
| 5 | Hyperglycinuria (HP:0003108) | 3.93793027 |
| 6 | Hyperglycinemia (HP:0002154) | 3.75491919 |
| 7 | Thin bony cortex (HP:0002753) | 3.69579047 |
| 8 | Gout (HP:0001997) | 3.55041001 |
| 9 | Xanthomatosis (HP:0000991) | 3.51622325 |
| 10 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.36237210 |
| 11 | Abnormality of glycine metabolism (HP:0010895) | 3.36237210 |
| 12 | Hemorrhage of the eye (HP:0011885) | 3.32568434 |
| 13 | Malnutrition (HP:0004395) | 3.25351848 |
| 14 | Breast hypoplasia (HP:0003187) | 3.22996443 |
| 15 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.19466752 |
| 16 | J-shaped sella turcica (HP:0002680) | 3.17414740 |
| 17 | Hypolipoproteinemia (HP:0010981) | 3.15816184 |
| 18 | Hyperammonemia (HP:0001987) | 3.12614971 |
| 19 | Hypoglycemic coma (HP:0001325) | 3.09294866 |
| 20 | Abnormal hair laboratory examination (HP:0003328) | 3.04787027 |
| 21 | Stridor (HP:0010307) | 3.04220402 |
| 22 | Deep venous thrombosis (HP:0002625) | 2.91999027 |
| 23 | Broad face (HP:0000283) | 2.86671815 |
| 24 | Upper limb amyotrophy (HP:0009129) | 2.83636043 |
| 25 | Distal upper limb amyotrophy (HP:0007149) | 2.83636043 |
| 26 | Microretrognathia (HP:0000308) | 2.81275779 |
| 27 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.80927558 |
| 28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.77593181 |
| 29 | Birth length less than 3rd percentile (HP:0003561) | 2.74687407 |
| 30 | Ileus (HP:0002595) | 2.73101688 |
| 31 | Pustule (HP:0200039) | 2.72535710 |
| 32 | Flat acetabular roof (HP:0003180) | 2.68818996 |
| 33 | Abnormality of nucleobase metabolism (HP:0010932) | 2.67896801 |
| 34 | Multiple enchondromatosis (HP:0005701) | 2.66327223 |
| 35 | Carpal bone hypoplasia (HP:0001498) | 2.65840748 |
| 36 | Oral leukoplakia (HP:0002745) | 2.63871541 |
| 37 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.63645848 |
| 38 | Eczematoid dermatitis (HP:0000976) | 2.62739451 |
| 39 | Hyperlipoproteinemia (HP:0010980) | 2.58957072 |
| 40 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.58497245 |
| 41 | Trismus (HP:0000211) | 2.57608863 |
| 42 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.53813331 |
| 43 | Dicarboxylic aciduria (HP:0003215) | 2.53813331 |
| 44 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.52961742 |
| 45 | Proximal tubulopathy (HP:0000114) | 2.52302647 |
| 46 | Right ventricular cardiomyopathy (HP:0011663) | 2.52113995 |
| 47 | Fat malabsorption (HP:0002630) | 2.51061885 |
| 48 | Megaloblastic anemia (HP:0001889) | 2.49744116 |
| 49 | Milia (HP:0001056) | 2.49584065 |
| 50 | Late onset (HP:0003584) | 2.47127182 |
| 51 | Easy fatigability (HP:0003388) | 2.45666384 |
| 52 | Abnormality of the anterior horn cell (HP:0006802) | 2.45400923 |
| 53 | Degeneration of anterior horn cells (HP:0002398) | 2.45400923 |
| 54 | Abnormality of purine metabolism (HP:0004352) | 2.42111825 |
| 55 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.41481419 |
| 56 | Hypoalphalipoproteinemia (HP:0003233) | 2.40770585 |
| 57 | Prolonged partial thromboplastin time (HP:0003645) | 2.40071776 |
| 58 | Abdominal distention (HP:0003270) | 2.39856396 |
| 59 | Cerebral palsy (HP:0100021) | 2.39287043 |
| 60 | Abnormality of serum amino acid levels (HP:0003112) | 2.37931952 |
| 61 | Growth hormone excess (HP:0000845) | 2.37099535 |
| 62 | Lethargy (HP:0001254) | 2.33840923 |
| 63 | Seborrheic dermatitis (HP:0001051) | 2.33380773 |
| 64 | Onycholysis (HP:0001806) | 2.31546592 |
| 65 | Increased IgE level (HP:0003212) | 2.31151317 |
| 66 | Nasal polyposis (HP:0100582) | 2.30050304 |
| 67 | Ketosis (HP:0001946) | 2.29801518 |
| 68 | Cervical subluxation (HP:0003308) | 2.28024397 |
| 69 | Widely patent fontanelles and sutures (HP:0004492) | 2.25166584 |
| 70 | Axonal loss (HP:0003447) | 2.23985256 |
| 71 | Aplasia/hypoplasia of the femur (HP:0005613) | 2.23304087 |
| 72 | Focal segmental glomerulosclerosis (HP:0000097) | 2.22863124 |
| 73 | Interstitial pulmonary disease (HP:0006530) | 2.22697085 |
| 74 | Hyperuricemia (HP:0002149) | 2.21867215 |
| 75 | Increased purine levels (HP:0004368) | 2.21867215 |
| 76 | Macrocytic anemia (HP:0001972) | 2.21768556 |
| 77 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.21632750 |
| 78 | IgM deficiency (HP:0002850) | 2.19896119 |
| 79 | Ragged-red muscle fibers (HP:0003200) | 2.18869826 |
| 80 | Biliary tract neoplasm (HP:0100574) | 2.18208948 |
| 81 | Distal lower limb muscle weakness (HP:0009053) | 2.18015043 |
| 82 | Abnormal biliary tract morphology (HP:0012440) | 2.18004029 |
| 83 | Generalized aminoaciduria (HP:0002909) | 2.17331050 |
| 84 | Distal lower limb amyotrophy (HP:0008944) | 2.15550362 |
| 85 | Alopecia of scalp (HP:0002293) | 2.13800190 |
| 86 | Progressive muscle weakness (HP:0003323) | 2.13618338 |
| 87 | Flattened epiphyses (HP:0003071) | 2.13151680 |
| 88 | Hypertensive crisis (HP:0100735) | 2.12194618 |
| 89 | Abnormal number of erythroid precursors (HP:0012131) | 2.11698946 |
| 90 | Acanthosis nigricans (HP:0000956) | 2.11015762 |
| 91 | Amelogenesis imperfecta (HP:0000705) | 2.10480546 |
| 92 | Fragile nails (HP:0001808) | 2.10265400 |
| 93 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.09086427 |
| 94 | Nausea (HP:0002018) | 2.09031827 |
| 95 | Abnormal cartilage morphology (HP:0002763) | 2.08988583 |
| 96 | Hypertriglyceridemia (HP:0002155) | 2.08771754 |
| 97 | Death in infancy (HP:0001522) | 2.08762765 |
| 98 | Glomerulosclerosis (HP:0000096) | 2.07926647 |
| 99 | Gastrointestinal dysmotility (HP:0002579) | 2.07610978 |
| 100 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.06319367 |
| 101 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.06114643 |
| 102 | Cholecystitis (HP:0001082) | 2.04469140 |
| 103 | Abnormal gallbladder physiology (HP:0012438) | 2.04469140 |
| 104 | Rough bone trabeculation (HP:0100670) | 2.04211197 |
| 105 | Abnormality of the nasal mucosa (HP:0000433) | 2.04032306 |
| 106 | Dysostosis multiplex (HP:0000943) | 2.03979040 |
| 107 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.03655179 |
| 108 | Hypophosphatemia (HP:0002148) | 2.02243087 |
| 109 | Short nail (HP:0001799) | 2.01987275 |
| 110 | Nail dystrophy (HP:0008404) | 2.01952018 |
| 111 | Prolonged neonatal jaundice (HP:0006579) | 2.01832800 |
| 112 | Polygenic inheritance (HP:0010982) | 2.00702836 |
| 113 | Abnormality of methionine metabolism (HP:0010901) | 2.00006053 |
| 114 | Testicular atrophy (HP:0000029) | 1.99338668 |
| 115 | B lymphocytopenia (HP:0010976) | 1.98906298 |
| 116 | Chronic bronchitis (HP:0004469) | 1.97923548 |
| 117 | Sparse eyelashes (HP:0000653) | 1.97869443 |
| 118 | Delayed CNS myelination (HP:0002188) | 1.97210923 |
| 119 | Reticulocytopenia (HP:0001896) | 1.96816454 |
| 120 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.96545483 |
| 121 | Selective tooth agenesis (HP:0001592) | 1.96436088 |
| 122 | Hand muscle atrophy (HP:0009130) | 1.95997777 |
| 123 | Systemic lupus erythematosus (HP:0002725) | 1.95849323 |
| 124 | Plantar hyperkeratosis (HP:0007556) | 1.95804206 |
| 125 | Impulsivity (HP:0100710) | 1.95493985 |
| 126 | Glycosuria (HP:0003076) | 1.94131892 |
| 127 | Abnormality of urine glucose concentration (HP:0011016) | 1.94131892 |
| 128 | Delayed epiphyseal ossification (HP:0002663) | 1.92553596 |
| 129 | Colon cancer (HP:0003003) | 1.92400013 |
| 130 | Abnormality of B cell number (HP:0010975) | 1.92293113 |
| 131 | Abnormal blistering of the skin (HP:0008066) | 1.91549744 |
| 132 | Abnormality of macrophages (HP:0004311) | 1.91413117 |
| 133 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.91402916 |
| 134 | Mucopolysacchariduria (HP:0008155) | 1.91402916 |
| 135 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.90956524 |
| 136 | Spastic diplegia (HP:0001264) | 1.90873553 |
| 137 | Irritability (HP:0000737) | 1.90463879 |
| 138 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.90077505 |
| 139 | Subcapsular cataract (HP:0000523) | 1.88180204 |
| 140 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.85805921 |
| 141 | Mediastinal lymphadenopathy (HP:0100721) | 1.85727354 |
| 142 | Increased serum ferritin (HP:0003281) | 1.85401353 |
| 143 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.84998340 |
| 144 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.84998340 |
| 145 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.84998340 |
| 146 | Obstructive sleep apnea (HP:0002870) | 1.84368687 |
| 147 | Ketoacidosis (HP:0001993) | 1.84066921 |
| 148 | Steatorrhea (HP:0002570) | 1.82972532 |
| 149 | Elevated alkaline phosphatase (HP:0003155) | 1.82792439 |
| 150 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.82768433 |
| 151 | Abnormal trabecular bone morphology (HP:0100671) | 1.81945438 |
| 152 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.81654500 |
| 153 | Hyperbilirubinemia (HP:0002904) | 1.80592934 |
| 154 | Abnormality of the intrinsic pathway (HP:0010989) | 1.80477027 |
| 155 | Pili torti (HP:0003777) | 1.80434674 |
| 156 | Long palpebral fissure (HP:0000637) | 1.79969274 |
| 157 | Ependymoma (HP:0002888) | 1.78162781 |
| 158 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.78000348 |
| 159 | Patellar aplasia (HP:0006443) | 1.77814602 |
| 160 | Metabolic acidosis (HP:0001942) | 1.77591462 |
| 161 | Gastrointestinal inflammation (HP:0004386) | 1.77389272 |
| 162 | Bowing of the arm (HP:0006488) | 1.76402629 |
| 163 | Bowed forearm bones (HP:0003956) | 1.76402629 |
| 164 | Polar cataract (HP:0010696) | 1.76240440 |
| 165 | Conjugated hyperbilirubinemia (HP:0002908) | 1.75943657 |
| 166 | Premature ovarian failure (HP:0008209) | 1.75715113 |
| 167 | Increased cerebral lipofuscin (HP:0011813) | 1.75353626 |
| 168 | Hyperacusis (HP:0010780) | 1.75040224 |
| 169 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.74894011 |
| 170 | Villous atrophy (HP:0011473) | 1.74894011 |
| 171 | Abnormal pancreas size (HP:0012094) | 1.74248904 |
| 172 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.73389853 |
| 173 | Broad distal phalanx of finger (HP:0009836) | 1.73090344 |
| 174 | Hepatocellular carcinoma (HP:0001402) | 1.72376418 |
| 175 | Woolly hair (HP:0002224) | 1.71289092 |
| 176 | Secondary amenorrhea (HP:0000869) | 1.69979399 |
| 177 | Abnormality of complement system (HP:0005339) | 1.69295906 |
| 178 | Wide cranial sutures (HP:0010537) | 1.68699956 |
| 179 | Abnormal hemoglobin (HP:0011902) | 1.68181404 |
| 180 | Bone pain (HP:0002653) | 1.67645601 |
| 181 | Hyperactive renin-angiotensin system (HP:0000841) | 1.67195954 |
| 182 | Abnormality of the common coagulation pathway (HP:0010990) | 1.67096193 |
| 183 | Posterior subcapsular cataract (HP:0007787) | 1.66840343 |
| 184 | Esophageal varix (HP:0002040) | 1.66292964 |
| 185 | Neoplasm of the pancreas (HP:0002894) | 1.65726969 |
| 186 | Rhabdomyolysis (HP:0003201) | 1.64697988 |
| 187 | Microvesicular hepatic steatosis (HP:0001414) | 1.64348303 |
| 188 | Brushfield spots (HP:0001088) | 1.64283227 |
| 189 | Vascular calcification (HP:0004934) | 1.63786225 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 5.38700482 |
| 2 | BUB1 | 4.61304890 |
| 3 | BCKDK | 2.88989081 |
| 4 | WEE1 | 2.85080031 |
| 5 | LMTK2 | 2.80172211 |
| 6 | EIF2AK1 | 2.78192984 |
| 7 | ACVR1B | 2.36530907 |
| 8 | MST1R | 2.21035495 |
| 9 | RPS6KB2 | 2.21029085 |
| 10 | SMG1 | 2.04863185 |
| 11 | STK38L | 2.03205980 |
| 12 | EIF2AK3 | 1.95527779 |
| 13 | NEK1 | 1.94264914 |
| 14 | MAP4K1 | 1.84738459 |
| 15 | TTK | 1.77852576 |
| 16 | STK16 | 1.75549418 |
| 17 | NEK2 | 1.66967556 |
| 18 | TSSK6 | 1.64750801 |
| 19 | MAPKAPK3 | 1.63470233 |
| 20 | MAP2K2 | 1.63320852 |
| 21 | TBK1 | 1.63171569 |
| 22 | ERN1 | 1.60362175 |
| 23 | MAP3K13 | 1.58263815 |
| 24 | NME2 | 1.53320694 |
| 25 | DYRK3 | 1.52267346 |
| 26 | SRPK1 | 1.47758261 |
| 27 | TESK2 | 1.47151027 |
| 28 | EPHB1 | 1.45508402 |
| 29 | RPS6KA4 | 1.42265804 |
| 30 | PLK4 | 1.41834861 |
| 31 | MAP3K3 | 1.41364855 |
| 32 | TNK2 | 1.41243290 |
| 33 | PASK | 1.40091904 |
| 34 | PIM2 | 1.38777688 |
| 35 | TESK1 | 1.38321136 |
| 36 | PAK4 | 1.34800097 |
| 37 | BMX | 1.33837741 |
| 38 | MAP3K8 | 1.29982870 |
| 39 | NME1 | 1.28901523 |
| 40 | PLK1 | 1.27107332 |
| 41 | TAOK1 | 1.26695152 |
| 42 | CDC7 | 1.26267185 |
| 43 | AURKB | 1.25567670 |
| 44 | BRSK2 | 1.23635885 |
| 45 | PRKCI | 1.22611819 |
| 46 | MAP3K11 | 1.20718589 |
| 47 | IRAK3 | 1.20343750 |
| 48 | MST4 | 1.17517603 |
| 49 | AKT3 | 1.15547349 |
| 50 | MUSK | 1.11890365 |
| 51 | BRAF | 1.11690746 |
| 52 | PRPF4B | 1.10609767 |
| 53 | IRAK4 | 1.09789705 |
| 54 | AURKA | 1.07496740 |
| 55 | MET | 1.04881962 |
| 56 | STK10 | 1.04380187 |
| 57 | CDK7 | 1.02342075 |
| 58 | PRKD2 | 1.01471087 |
| 59 | MAP3K1 | 1.00480757 |
| 60 | PKN2 | 1.00244894 |
| 61 | SIK3 | 0.96665000 |
| 62 | KDR | 0.95978595 |
| 63 | LRRK2 | 0.93984889 |
| 64 | ICK | 0.92393822 |
| 65 | MAP3K10 | 0.89611979 |
| 66 | GRK6 | 0.89177268 |
| 67 | CHEK2 | 0.86107457 |
| 68 | MARK2 | 0.85051833 |
| 69 | MAP3K9 | 0.84849577 |
| 70 | CSK | 0.83890615 |
| 71 | PDPK1 | 0.83147425 |
| 72 | CDK4 | 0.82934036 |
| 73 | TRIB3 | 0.82041514 |
| 74 | FLT3 | 0.80650977 |
| 75 | ZAP70 | 0.79084628 |
| 76 | FGFR4 | 0.76035831 |
| 77 | EEF2K | 0.75101348 |
| 78 | SCYL2 | 0.74999693 |
| 79 | MAP2K6 | 0.73061078 |
| 80 | PLK3 | 0.72916837 |
| 81 | RPS6KA2 | 0.71060136 |
| 82 | BRSK1 | 0.70621969 |
| 83 | MAP2K3 | 0.69650973 |
| 84 | DYRK1B | 0.68899323 |
| 85 | ARAF | 0.68025110 |
| 86 | ATR | 0.66803040 |
| 87 | IKBKE | 0.66451934 |
| 88 | EPHB2 | 0.66260205 |
| 89 | TYK2 | 0.65830514 |
| 90 | WNK3 | 0.65047603 |
| 91 | MAP3K2 | 0.64710824 |
| 92 | MAP2K1 | 0.64665452 |
| 93 | IRAK2 | 0.64531821 |
| 94 | PIM1 | 0.63388796 |
| 95 | DAPK1 | 0.62887647 |
| 96 | PTK6 | 0.62591946 |
| 97 | PAK1 | 0.62054059 |
| 98 | MAP3K6 | 0.60516294 |
| 99 | MAPK15 | 0.60022981 |
| 100 | HIPK2 | 0.59227818 |
| 101 | CDK6 | 0.58269869 |
| 102 | TGFBR1 | 0.57826894 |
| 103 | SIK1 | 0.57383380 |
| 104 | RIPK4 | 0.57304035 |
| 105 | MAPK11 | 0.56719992 |
| 106 | ZAK | 0.55524221 |
| 107 | TLK1 | 0.55518947 |
| 108 | VRK1 | 0.54322600 |
| 109 | TAOK2 | 0.53865272 |
| 110 | BTK | 0.53253192 |
| 111 | CSNK2A1 | 0.51804086 |
| 112 | PTK2 | 0.50388623 |
| 113 | MELK | 0.46380985 |
| 114 | MAP3K7 | 0.46363252 |
| 115 | CHEK1 | 0.46026996 |
| 116 | STK4 | 0.45652022 |
| 117 | RIPK1 | 0.45177911 |
| 118 | RPS6KC1 | 0.44711472 |
| 119 | RPS6KL1 | 0.44711472 |
| 120 | CSF1R | 0.44176797 |
| 121 | PIK3CG | 0.44154909 |
| 122 | ERBB2 | 0.44051092 |
| 123 | MTOR | 0.44005257 |
| 124 | AKT2 | 0.43395535 |
| 125 | LATS1 | 0.43371644 |
| 126 | CSNK2A2 | 0.42849009 |
| 127 | PDK1 | 0.42548512 |
| 128 | CDC42BPA | 0.41663621 |
| 129 | LIMK1 | 0.40720522 |
| 130 | JAK3 | 0.39382756 |
| 131 | MAPKAPK2 | 0.39323154 |
| 132 | ILK | 0.38070538 |
| 133 | FRK | 0.36530609 |
| 134 | PRKG2 | 0.35426415 |
| 135 | STK38 | 0.34994186 |
| 136 | ITK | 0.34763863 |
| 137 | STK24 | 0.34495666 |
| 138 | CDK2 | 0.34267374 |
| 139 | ABL2 | 0.33346134 |
| 140 | STK3 | 0.33050547 |
| 141 | IKBKB | 0.32036790 |
| 142 | RPS6KA1 | 0.31011049 |
| 143 | RPS6KA6 | 0.30047039 |
| 144 | MATK | 0.30012118 |
| 145 | TAOK3 | 0.29991244 |
| 146 | KSR2 | 0.27437666 |
| 147 | VRK2 | 0.27167045 |
| 148 | FER | 0.25431320 |
| 149 | MAP3K14 | 0.23906205 |
| 150 | SRC | 0.22583736 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.04469202 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 2.81384786 |
| 3 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.41813639 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 2.35861071 |
| 5 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.32302831 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.24255250 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.24163135 |
| 8 | Ribosome_Homo sapiens_hsa03010 | 2.13529500 |
| 9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.08839423 |
| 10 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.04626604 |
| 11 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.04093507 |
| 12 | Mismatch repair_Homo sapiens_hsa03430 | 2.01072049 |
| 13 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.98302832 |
| 14 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.93897122 |
| 15 | RNA polymerase_Homo sapiens_hsa03020 | 1.88487135 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.82787656 |
| 17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.79270838 |
| 18 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.78745301 |
| 19 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.74445462 |
| 20 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.73264556 |
| 21 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.73121366 |
| 22 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.71205614 |
| 23 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.67819200 |
| 24 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.67731610 |
| 25 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.64634724 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.63510093 |
| 27 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.61177408 |
| 28 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.56754877 |
| 29 | Spliceosome_Homo sapiens_hsa03040 | 1.55917282 |
| 30 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.54727408 |
| 31 | RNA transport_Homo sapiens_hsa03013 | 1.54497770 |
| 32 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.51644732 |
| 33 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.50943510 |
| 34 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.48739755 |
| 35 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.47558736 |
| 36 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.47250409 |
| 37 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.46594838 |
| 38 | Carbon metabolism_Homo sapiens_hsa01200 | 1.46106087 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.45941174 |
| 40 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.45481272 |
| 41 | Sulfur relay system_Homo sapiens_hsa04122 | 1.44877011 |
| 42 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.43635765 |
| 43 | Histidine metabolism_Homo sapiens_hsa00340 | 1.43523020 |
| 44 | Base excision repair_Homo sapiens_hsa03410 | 1.42599995 |
| 45 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38134915 |
| 46 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.36371386 |
| 47 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.31929704 |
| 48 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.31810247 |
| 49 | Peroxisome_Homo sapiens_hsa04146 | 1.31266376 |
| 50 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.30025411 |
| 51 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.28961452 |
| 52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.23684717 |
| 53 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.21568839 |
| 54 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.20945517 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.18304201 |
| 56 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.16960926 |
| 57 | Hepatitis C_Homo sapiens_hsa05160 | 1.11505344 |
| 58 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.09945913 |
| 59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.09511389 |
| 60 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.08924037 |
| 61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.08568473 |
| 62 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.08267088 |
| 63 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.05577541 |
| 64 | Retinol metabolism_Homo sapiens_hsa00830 | 1.05117556 |
| 65 | Cell cycle_Homo sapiens_hsa04110 | 1.05065015 |
| 66 | Galactose metabolism_Homo sapiens_hsa00052 | 0.99702533 |
| 67 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97906040 |
| 68 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.96089863 |
| 69 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.95285170 |
| 70 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.94030876 |
| 71 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.93546978 |
| 72 | Homologous recombination_Homo sapiens_hsa03440 | 0.91953296 |
| 73 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.90358910 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.89321976 |
| 75 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.87621469 |
| 76 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86569375 |
| 77 | Lysosome_Homo sapiens_hsa04142 | 0.86496767 |
| 78 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.85406692 |
| 79 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.82463112 |
| 80 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.80575680 |
| 81 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.78718107 |
| 82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78497188 |
| 83 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.77843875 |
| 84 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.77403510 |
| 85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77023165 |
| 86 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.74853654 |
| 87 | Purine metabolism_Homo sapiens_hsa00230 | 0.74201427 |
| 88 | Bile secretion_Homo sapiens_hsa04976 | 0.74052823 |
| 89 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.73298326 |
| 90 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.72839049 |
| 91 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.71861311 |
| 92 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.71727755 |
| 93 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.70353798 |
| 94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.69433662 |
| 95 | Metabolic pathways_Homo sapiens_hsa01100 | 0.67961899 |
| 96 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.67247173 |
| 97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.66642807 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66369983 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62476138 |
| 100 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.62186164 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.61699230 |
| 102 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.58314255 |
| 103 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.56496066 |
| 104 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.56240046 |
| 105 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.55846813 |
| 106 | Bladder cancer_Homo sapiens_hsa05219 | 0.53714539 |
| 107 | Apoptosis_Homo sapiens_hsa04210 | 0.53414902 |
| 108 | Protein export_Homo sapiens_hsa03060 | 0.52402908 |
| 109 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.52297926 |
| 110 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.50171104 |
| 111 | Shigellosis_Homo sapiens_hsa05131 | 0.49518291 |
| 112 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.48293994 |
| 113 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.47578595 |
| 114 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.47379596 |
| 115 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.47346355 |
| 116 | RNA degradation_Homo sapiens_hsa03018 | 0.45356875 |
| 117 | ABC transporters_Homo sapiens_hsa02010 | 0.45147084 |
| 118 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.44516775 |
| 119 | Mineral absorption_Homo sapiens_hsa04978 | 0.43104728 |
| 120 | Thyroid cancer_Homo sapiens_hsa05216 | 0.42723603 |
| 121 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.42432862 |
| 122 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.40707550 |
| 123 | Prion diseases_Homo sapiens_hsa05020 | 0.40654939 |
| 124 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.40051184 |
| 125 | Basal transcription factors_Homo sapiens_hsa03022 | 0.39130366 |
| 126 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38251037 |
| 127 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38132165 |
| 128 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.36923081 |
| 129 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.36310623 |
| 130 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35465126 |
| 131 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.35434073 |
| 132 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.34546468 |
| 133 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34452756 |
| 134 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.33911626 |
| 135 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.33785076 |
| 136 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.33075306 |
| 137 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32581621 |
| 138 | Lysine degradation_Homo sapiens_hsa00310 | 0.31719486 |
| 139 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.30655816 |
| 140 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.30406952 |
| 141 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.29564492 |
| 142 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.29393767 |
| 143 | Salmonella infection_Homo sapiens_hsa05132 | 0.28998315 |
| 144 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.28080292 |
| 145 | Tight junction_Homo sapiens_hsa04530 | 0.27534684 |

